Abbott Laboratories needs to decide whether to jump back into the merger arena or rely on internal revenue sources to drive growth and support Abbott's shares, which have leveled off since climbing 40% to a five-year peak of $63.62 during the 12 months ended in March.
The CMS is considering covering a brain stimulation therapy device that helps treat depression in patients who don't respond to other treatments. Hospitals could receive up to $30,000 per patient if the agency covers the device.
HonorHealth saved $1.5 million when it renegotiated prices for knee and hip implants. Hospitals nationwide are looking for ways to eliminate cost variation in this service line.
Sixty-two percent of health system executives support Amazon's growing presence in the medical supply sector and nearly the same amount said the company could successfully deliver supplies faster and at a lower price, according to a new survey.
Chicago-based hospital bed and medical device supplier Hill-Rom Holdings appointed John Groetelaars president and CEO, effective May 14.
In the Medical Device Safety Action Plan, FDA regulators set forth ideas for getting safer devices to patients faster.
The FDA's approval process for medical devices has been criticized for years for failing to catch problems with defective implants.
Generic-drug manufacturers, which source most of their active ingredients from China and India, could be hit the hardest by President Donald Trump's proposed tariffs, experts said.
The agency approved marketing a device that can detect diabetic retinopathy by analyzing images of the eye.
U.S. health officials are placing new restrictions on a permanent contraceptive implant that has been subject to reports of painful complications from thousands of women. But the metal implant called Essure will remain on the market.
The U.S. Justice Department settlement involves claims that Alere, which was acquired by Abbott Laboratories last year, sold its Triage-branded devices to hospitals from 2006 to 2012 despite customer complaints warning of erroneous results.
When the Apple Watch was paired with a machine-learning algorithm, it could accurately spot irregular heartbeats, according to a new study.